Firefly Neuro (AIFF): O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti
Firefly Neuroscience, Inc (AIFF) sog'liqni saqlash gigantlari bilan klinik ittifoqlar tarmog'ini organik ravishda kengaytirmoqda. O'sish BrainScope tijoratlashtirilishi, SaaS obunalar va FDA tasdiqlari hisobiga ta'minlanmoqda. Biroq, shifokorlar tomonidan neyromonitoringning sekin joriy etilishi va sertifikatlashtirish murakkabliklari to'siqlarni yuzaga keltirmoqda. PEG koeffitsiyenti asosidagi past baholanganlik darajasi, 0.00 ko'rsatkichning joriy qiymati sifatida xizmat qilgan holda, ortiqcha shovqinlarsiz bozor realligini aniq namoyish etadi.
Firefly Neuroscience, Inc (AIFF) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- balans kapitallashuvi ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Firefly Neuroscience, Inc|AIFF - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati fireflyneuro.com|AIFF - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Firefly Neuro|AIFF - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Firefly Neuroscience|Shoshilinch likvidlik fireflyneuro.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
AIFF - Sof daromad|Prognoz qilingan kelajakdagi foyda Firefly Neuroscience, Inc|AIFF - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Firefly Neuro|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Firefly Neuro|AIFF - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Firefly Neuroscience|AIFF - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi fireflyneuro.com|AIFF - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Firefly Neuroscience, Inc
Kompaniyaning jamlanma tahliliyoti:Firefly Neuroscience, Inc., AIFF
Metrikaning har kuni qayta hisoblanishi choraklik hisobotlarning kechikishini chetlab o'tib, foyda o'sish sur'atlaridagi o'zgarishlarga bozor reaksiyalarini tezkorlik bilan qayd etish imkonini beradi. Ushbu koeffitsient joriy P/E multiplikatorini biznesning o'sish sur'ati bilan solishtiradi, bunda birdan past qiymat aktivning qadrini past baholaganini anglatadi. Firefly Neuroscience, Inc (AIFF) uchun ushbu muvozanat juda muhimdir, chunki klinikalar BNA AI platformasiga o'tishidagi yuqori xarajatlar daromadning barqaror kengayishini kafolatlaydi. Kompaniyaning fundamental salohiyati PEG koeffitsientini kuzatish orqali ochiladi. Ushbu ko'rsatkich tez o'sayotgan texnologik sektorda kirish nuqtasini o'z vaqtida aniqlashga yordam beradi.
Firefly Neuroscience, Inc raqobatchilari
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Inc|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RGC|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acadia-pharm.com|XENE: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati VKTX (Viking Therapeutics Inc)|Narxning foydaga va o‘sish sur’atiga nisbati Supernus Pharma|Narxning foydaga va o‘sish sur’atiga nisbati CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Biohaven - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AMLX|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|PRAX (Praxis Corp) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AVXL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda ceribell.com (CBLL)|Narx-foyda va o‘sish multiplikatori PRTA|PEG multiplikatori Alector Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|OMER (omeros.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neurogene Inc. NGNE|acimmune.com (ACIU) - O‘sish sur’atiga tuzatilgan narx-foyda|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Neumora NMRA|SCLX: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Tevogen Bio Inc.|ACOG (Alpha Cognition Inc) - PEG multiplikatori|cogrx.com (CGTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori IKT|SAVA - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Assertio ASRT|COYA: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VistaGen Therapeutics Inc - PEG multiplikatori|Ovid Therapeutics Inc. (OVID) - Narx-foyda va o‘sish multiplikatori|ABOS: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda CervoMed, Inc. (CRVO)|Narx-foyda va o‘sish multiplikatori ATHE|CLNN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori PEPG|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati jupiterneurosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Grace Tx - PEG multiplikatori|Klotho Neurosciences Inc (KLTO) - Narx-foyda va o‘sish multiplikatori|NRSN: PEG multiplikatori|revivapharma.com (RVPH) - PEG multiplikatori|MTVA (MetaVia Inc.) - PEG multiplikatori|NeurAxis Inc. (NRXS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori HSDT|PASG: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori NEUP (Neuphoria Therapeutics)|NERV (minervaneurosciences.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|ADXN (Addex Therapeutics Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ALZN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Cyclerion Therapeutics, Inc. (CYCN)|Narx-foyda va o‘sish multiplikatori PTIX|PEG multiplikatori Pasithea|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|ATXI (Avenue Therapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Cara Therapeutics Inc (CARA) - O‘sish sur’atiga tuzatilgan narx-foyda|Chromocell Therapeutics - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ELYM|ITCI: PEG multiplikatori|LBPH - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Marinus|NKGN: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NRBO|SAGE - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori SNPX (Synaptogenix)|TRVN (Trevena Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|WENA: Narxning foydaga va o‘sish sur’atiga nisbati|CERE (Cerevel Therapeutics) - Narx-foyda va o‘sish multiplikatori
